- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/426 - 1,3-Thiazoles
Patent holdings for IPC class A61K 31/426
Total number of patents in this class: 3244
10-year publication summary
|
203
|
203
|
224
|
242
|
227
|
245
|
253
|
214
|
215
|
115
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19859 |
41 |
| Genfit | 269 |
40 |
| Astellas Pharma Inc. | 1088 |
37 |
| Actelion Pharmaceuticals Ltd | 532 |
30 |
| EyePoint Pharmaceuticals, Inc. | 101 |
28 |
| Bristol-myers Squibb Company | 4872 |
27 |
| Dompé Farmaceutici S.p.A. | 268 |
27 |
| Romark Laboratories L.C. | 52 |
25 |
| University of Florida Research Foundation, Inc. | 4000 |
24 |
| Purdue Research Foundation | 3576 |
24 |
| Takeda Pharmaceutical Company Limited | 2707 |
23 |
| Vanda Pharmaceuticals, Inc. | 354 |
22 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3364 |
21 |
| Centre National de La Recherche Scientifique | 10395 |
20 |
| Teijin Pharma Limited | 261 |
19 |
| vTv Therapeutics LLC | 152 |
19 |
| Duke University | 3063 |
18 |
| Shionogi & Co., Ltd. | 860 |
18 |
| Allergan, Inc. | 2361 |
17 |
| Avexxin AS | 46 |
17 |
| Other owners | 2747 |